OPKO Health, Inc. (OPK) capitalization

Current snapshot

Market Cap
$860.8M
755.1M shares × $1.14 · as of last filing 2026-03-31
Net Worth
$1.20B
Stockholders' equity · 2026-03-31
Enterprise Value
$925.9M
Market cap + debt − cash
Net Debt
$65.1M
Debt $396.9M − Cash $331.9M

Annual history

One row per fiscal year (10-K). Market cap uses split-adjusted closing price on the fiscal-year-end date × shares outstanding.

Period End Market Cap
FY'25 2025-12-31 $946.4M
FY'24 2024-12-31 $1.02B
FY'23 2023-12-31 $1.14B
FY'22 2022-12-31 $898.8M
FY'21 2021-12-31 $3.12B
FY'20 2020-12-31 $2.53B
FY'19 2019-12-31 $875.3M
FY'18 2018-12-31 $1.70B
FY'17 2017-12-31 $2.74B
FY'16 2016-12-31 $5.17B
FY'15 2015-12-31 $5.48B
FY'14 2014-12-31 $4.51B
FY'13 2013-12-31 $3.49B
FY'12 2012-12-31 $1.43B
FY'11 2011-12-31 $1.38B
FY'11 2010-12-31 $936.2M
FY'11 2009-12-31 $426.7M

Quarterly history

One row per quarter (10-Q and Q4 from 10-K). Market cap uses split-adjusted closing price on the quarter-end date × shares outstanding.

Period End Market Cap
Q1'26 2026-03-31 $865.1M
Q4'25 2025-12-31 $956.4M
Q3'25 2025-09-30 $1.21B
Q2'25 2025-06-30 $1.04B
Q1'25 2025-03-31 $1.11B
Q4'24 2024-12-31 $987.2M
Q3'24 2024-09-30 $1.49B
Q2'24 2024-06-30 $871.5M
Q1'24 2024-03-31 $848.3M
Q4'23 2023-12-31 $1.05B
Q3'23 2023-09-30 $1.20B
Q2'23 2023-06-30 $1.63B
Q1'23 2023-03-31 $1.10B
Q4'22 2022-12-31 $965.8M
Q3'22 2022-09-30 $1.42B
Q2'22 2022-06-30 $1.80B
Q1'22 2022-03-31 $2.27B
Q4'21 2021-12-31 $3.28B
Q3'21 2021-09-30 $2.38B
Q2'21 2021-06-30 $2.62B
Q1'21 2021-03-31 $2.75B
Q4'20 2020-12-31 $2.65B
Q3'20 2020-09-30 $2.36B
Q2'20 2020-06-30 $2.18B
Q1'20 2020-03-31 $897.6M
Q4'19 2019-12-31 $984.6M
Q3'19 2019-09-30 $1.39B
Q2'19 2019-06-30 $1.50B
Q1'19 2019-03-31 $1.61B
Q4'18 2018-12-31 $1.85B
Q3'18 2018-09-30 $1.94B
Q2'18 2018-06-30 $2.63B
Q1'18 2018-03-31 $1.77B
Q4'17 2017-12-31 $2.74B
Q3'17 2017-09-30 $3.84B
Q2'17 2017-06-30 $3.71B
Q1'17 2017-03-31 $4.48B
Q4'16 2016-12-31 $5.19B
Q3'16 2016-09-30 $5.85B
Q2'16 2016-06-30 $5.20B
Q1'16 2016-03-31 $5.69B
Q4'15 2015-12-31 $5.48B
Q3'15 2015-09-30 $4.34B
Q2'15 2015-06-30 $7.43B
Q1'15 2015-03-31 $6.50B
Q4'14 2014-12-31 $4.51B
Q3'14 2014-09-30 $3.64B
Q2'14 2014-06-30 $3.79B
Q1'14 2014-03-31 $3.86B
Q4'13 2013-12-31 $3.49B
Q3'13 2013-09-30 $3.59B
Q2'13 2013-06-30 $2.39B
Q1'13 2013-03-31 $2.57B
Q4'12 2012-12-31 $1.43B
Q3'12 2012-09-30 $1.25B
Q2'12 2012-06-30 $1.37B
Q1'12 2012-03-31 $1.41B
Q4'11 2011-12-31 $1.46B
Q3'11 2011-09-30 $1.26B
Q2'11 2011-06-30 $1.06B
Q1'12 2011-03-31 $973.7M
Q4'11 2010-12-31 $937.4M
Q3'11 2010-09-30
Q2'11 2010-06-30

Methodology

Every figure on this page traces back to SEC EDGAR XBRL company-facts filings (OPK CIK 0000944809), tagged with the us-gaap and dei taxonomies. Filing-anchored figures are rendered server-side: the market cap and enterprise value tiles use the split-adjusted close on the latest reported period-end × shares outstanding, so they reconcile with the equity / debt / cash figures from that same filing. The two price-anchored tiles (market cap + enterprise value) re-anchor on the most recent daily close in the browser when JavaScript is enabled; shares outstanding and debt / cash stay filing-anchored, so the EV bridge still uses the latest statement of financial position. Historical share prices come from our total-returns daily history (split-adjusted); historical market caps are calibrated against today's share count to correct for SEC retroactive split restatements.

For the exact XBRL concepts and formulas, see the methodology reference for net worth, debt, cash, market cap, enterprise value, net debt, shares outstanding, and the historical-market-cap calibration.

Related tickers

BOOM

DMC Global Inc.

IRON

Disc Medicine, Inc.

SF

STIFEL FINANCIAL CORP